European Gene Therapy Markets
European Gene Therapy Markets
RELEASE DATE
03-Dec-2002
03-Dec-2002
REGION
Europe
Europe
Research Code: B112-01-00-00-00
SKU: HC01008-EU-MR_04950
$4,950.00
In stock
SKU
HC01008-EU-MR_04950
Description
Cell Therapies; Gene Therapies: corrective gene delivery, therapeutic gene delivery, ribozymes, antisense, prodrug + enzyme delivery. Not DNA vaccines (therapeutic or prophylactic). In relation to the European market; in particular, the way in which these therapies would be applied to European therapeutic methodology.
Table of Contents
Market Overview
- Introduction and Presentation
A New Definition of Medicine
- A Brief History
- Market Definition
- The European Perspective
- Glossary of Terms
Technology Overview
- Viral Vector Technology
- Non-Viral Vector Technology
- Gene-Related Therapeutic Technology
Corporate Strategy
Product Strategy
- Defining the Corporate Strategy
- Commercial Strategy
- Development Strategy
- Patent Strategy
- Public Relations Strategy
Market Overview
Forecasts for the Total Gene Therapy Market
Market Overview
Forecasts for the Cancer Gene Therapy Market
Market Overview
Forecasts for the Vascular Diseases Gene Therapy Market
Market Overview
Forecasts for the Monogenic Disease Gene Therapy Market
Frost & Sullivan 2002 ME Awards for Gene Therapy
Related Research
Popular Topics
Cell Therapies; Gene Therapies: corrective gene delivery, therapeutic gene delivery, ribozymes, antisense, prodrug + enzyme delivery. Not DNA vaccines (therapeutic or prophylactic). In relation to the European market; in particular, the way in which these therapies would be applied to European therapeutic methodology.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | B112-01-00-00-00 |
Is Prebook | No |